(Q37755957)

22 August 2017

1 reference

title

How we approach patient evaluation for hematopoietic stem cell transplantation (English)

1 reference

stem cell transplantation

22 August 2017

1 reference

1 reference

M Hamadani

1

0 references

author name string

M Craig

series ordinal

2

1 reference

22 August 2017

F T Awan

series ordinal

3

1 reference

22 August 2017

S M Devine

series ordinal

4

1 reference

22 August 2017

language of work or name

English

0 references

publication date

17 May 2010

1 reference

Bone Marrow Transplantation

22 August 2017

published in

1 reference

22 August 2017

volume

45

1 reference

22 August 2017

issue

8

1 reference

22 August 2017

page(s)

1259-1268

1 reference

https://scigraph.springernature.com/pub.10.1038/bmt.2010.94

22 August 2017

exact match

0 references

cites work

Hematopoietic stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

Safety and efficacy of hematopoietic stem cell collection from mobilized peripheral blood in unrelated volunteers: 12 years of single-center experience in 3928 donors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

Treatment of gonadal damage in recipients of allogeneic or autologous transplantation for haematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

Prevalence of conception and pregnancy outcomes after hematopoietic cell transplantation: report from the Bone Marrow Transplant Survivor Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

Fertility and risk factors for elevated infertility concern in 10-year hematopoietic cell transplant survivors and case-matched controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

Follow-up of ovarian function post-chemotherapy following ovarian cryopreservation and transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

Myeloablative therapy and bone marrow transplantation in Jehovah's Witnesses with malignancies: single center experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

SCT in Jehovah's Witnesses: the bloodless transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

Allogeneic stem cell transplantation following reduced-intensity conditioning can induce durable clinical and molecular remissions in relapsed lymphomas: pre-transplant disease status and histotype heavily influence outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

High disease burden is associated with poor outcomes for patients with acute myeloid leukemia not in remission who undergo unrelated donor cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

Allogeneic stem cell transplantation for patients with relapsed chemorefractory aggressive non-hodgkin lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. UK Medical Research Council Adult and Children's Leukaemia Working Par

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

Long-term outcome after allogeneic hematopoietic stem cell transplantation for advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Société Française de Greffe de Moelle (SFGM).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

Individual physician practice variation in hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

Comorbidities, not age, impact outcomes in autologous stem cell transplant for relapsed non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

Pulmonary complications in bone marrow transplantation: a practical approach to diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

Bronchiolitis obliterans syndrome (BOS), bronchiolitis obliterans organizing pneumonia (BOOP), and other late-onset noninfectious pulmonary complications following allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

Acute lung injury after allogeneic stem cell transplantation: is the lung a target of acute graft-versus-host disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

Predictive value of pulmonary function tests before marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

Chronic GVHD and pretransplantation abnormalities in pulmonary function are the main determinants predicting worsening pulmonary function in long-term survivors after stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

Pretransplant pulmonary function tests predict risk of mortality following fractionated total body irradiation and allogeneic peripheral blood stem cell transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

The effect of smoking on allogeneic transplant outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

Outcome of allogeneic hematopoietic stem cell transplantation in patients with low left ventricular ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

Iron overload in hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

Elevated pretransplant serum ferritin is associated with inferior survival following nonmyeloablative allogeneic transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

Effect of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

Chronic kidney disease after myeloablative allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

Acute renal failure after nonmyeloablative stem cell transplantation in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

Acute renal failure requiring dialysis after allogeneic blood and marrow transplantation identifies very poor prognosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

Results of autologous stem cell transplant in multiple myeloma patients with renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

Moderate renal function impairment does not affect outcomes of reduced-intensity conditioning with fludarabine and melphalan for allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

Dialysis-dependent renal failure in patients with myeloma can be reversed by high-dose myeloablative therapy and autotransplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

Retrospective study on the impact of hepatitis B and hepatitis C virus infection on hematopoietic stem cell transplantation in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

Hepatitis B virus reactivation following allogeneic hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

How I treat and monitor viral hepatitis B infection in patients receiving intensive immunosuppressive therapies or undergoing hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem cell transplantation for hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

Autologous stem cell transplantation for HIV-associated lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

High-dose therapy and autologous peripheral blood stem cell transplantation as salvage treatment for AIDS-related lymphoma: long-term results of the Italian Cooperative Group on AIDS and Tumors (GICAT) study with analysis of prognostic factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

Dose-reduced busulfan, cyclophosphamide, and autologous stem cell transplantation for human immunodeficiency virus-associated lymphoma: AIDS Malignancy Consortium study 020.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

Allogeneic hematopoietic cell transplantation in human immunodeficiency virus-positive patients with hematologic disorders: a report from the center for international blood and marrow transplant research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

Generation of HIV-1-specific CD8+ cell responses following allogeneic hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

How I treat EBV lymphoproliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

Invasive aspergillosis before allogeneic hematopoietic stem cell transplantation: 10-year experience at a single transplant center

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

High-dose chemotherapy and autologous hematopoietic progenitor cell transplantation for non-Hodgkin's lymphoma in patients >65 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

Pre-transplantation physical and mental functioning is strongly associated with self-reported recovery from stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

Stress among allogeneic bone marrow transplantation patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

Supraventricular tachyarrhythmias after hematopoietic stem cell transplantation: incidence, risk factors and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

Reduced-intensity conditioning allogeneic stem cell transplantation in HIV patients with hematologic malignancies: yes, we can

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

Follow-up of healthy donors receiving granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization and collection. Results of the Spanish Donor Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

7 January 2021

Outcomes after hematopoietic stem-cell transplantation for hematologic malignancies in patients with or without advance care planning

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

7 January 2021

Discrepancies between patient and physician estimates for the success of stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

7 January 2021

Allogeneic bone marrow transplantation for acute leukemia in patients over the age of 40 years. Acute Leukemia Working Party of the European Group for Bone Marrow Transplantation (EBMT)

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

7 January 2021

Outcome after allogeneic bone marrow transplant for leukemia in older adults

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

7 January 2021

Prediction and prevention of transplant-related mortality from pulmonary causes after total body irradiation and allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

7 January 2021

Serious cardiac complications during bone marrow transplantation at the University of Minnesota, 1977-1997

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

7 January 2021

Severe cardiac toxicity in hematological stem cell transplantation: predictive value of reduced left ventricular ejection fraction

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

7 January 2021

Predictive value of left ventricular ejection fraction in stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

7 January 2021

Predictive value of QT dispersion for acute heart failure after autologous and allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

7 January 2021

Electrocardiogram is very useful for predicting acute heart failure following myeloablative chemotherapy with hematopoietic stem cell transplantation rescue

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

7 January 2021

Elevated pretransplant ferritin is associated with a lower incidence of chronic graft-versus-host disease and inferior survival after myeloablative allogeneic haematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

7 January 2021

Elevated ferritin is associated with relapse after autologous hematopoietic stem cell transplantation for lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

7 January 2021

Autologous stem-cell transplantation in patients with HIV-related lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

7 January 2021

Current practices in the oral management of the patient undergoing chemotherapy or bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

7 January 2021

A retrospective investigation of advanced periodontal disease as a risk factor for septicemia in hematopoietic stem cell and bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

7 January 2021

Perceived social support, family environment and psychosocial recovery in bone marrow transplant long-term survivors

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.94

7 January 2021

Identifiers

DOI

10.1038/BMT.2010.94

1 reference

22 August 2017

1 reference